Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
78 Cards in this Set
- Front
- Back
Acute Lymphoblastic Leukemia: Epi
|
77% of all childhood leukemias
|
|
Acute Lymphoblastic Leukemia: Initial presentation
|
Nonspecific, brief onsent
*Fever, anorexia, fatigue * Bone and joint pain (1/4), especially lower extremities |
|
Acute Lymphoblastic Leukemia: Later Signs/Sx
|
1. Bone marrow failure: pallor, brusing, epistaxis
2. Petechiae, purpura, mucous membrane bleeding, LAD, HSM, joint swelling |
|
Acute Lymphoblastic Leukemia: Key to Bone/Joint Pain
|
1/4 ALL patients present this way so have to keep this in the differential for bone/joint pain
|
|
Acute Lymphoblastic Leukemia: LAD distribution
|
- Suprclavicular and axillary are more suspicious
|
|
Acute Lymphoblastic Leukemia: Dx Tests
|
1. Peripheral Blood
2. BM aspirate |
|
Acute Lymphoblastic Leukemia: Peripheral blood findings
|
a. anemia
b. thrombocytopenia c. OFTEN do not see malignant cells d. Most WBC < 10k --> Atypical lymphocytes |
|
Acute Lymphoblastic Leukemia: BM findings
|
- Lymphoblasts
|
|
Acute Lymphoblastic Leukemia: Tx
|
1. Remission Induction
2. CNS Treatment (Phase 2) 3. Maintenance |
|
Acute Lymphoblastic Leukemia: Remission Rates
|
98% in 4-5w
|
|
Acute Lymphoblastic Leukemia: CNS Treatment
|
Intrathecal and intensive systemic --> Decreases CNS relapse rate to 5%
For all ALL b/c ALL likes to hide in CNS (And testes) |
|
Acute Lymphoblastic Leukemia: Maintenance phase time
|
2-3y
*Includes intrathecal therapy as well |
|
Acute Lymphoblastic Leukemia: What Tx NOT used
|
*Radiation: Poor brain penetration, hard to irradiate all of blood...
*Many side effects |
|
Acute Lymphoblastic Leukemia: Complications
|
1. Major impediment is relapse
2. Pneumocytis carinii 3. Other infections |
|
Acute Lymphoblastic Leukemia: Relapse Rates and Sites/Characteristics
|
*15-20% overall
*Increased ICP or isolated CN palsies * Testicular relapse in 1-2% of boys |
|
Acute Lymphoblastic Leukemia: Tumor Lysis Syndrome
|
*No exclusive to this --> but any large tumor load (high WBC count > 50K or so
a. Hyperuricemia b. electrolyte imbalance, K, P, Ca c. Renal failure |
|
Acute Lymphoblastic Leukemia: Tumor Lysis syndrome Tx
|
1. Hydration BEFORE and after
2. alkalinize urine 3. Prevent uric acid formation (pharm) |
|
Acute Lymphoblastic Leukemia: Prognosis
|
VERY Good
1. > 80% 5-year |
|
Acute Lymphoblastic Leukemia: Bad prognostic factors
|
1. Age < 1 or > 10y at Dx
2. > 100k WBC 3. Slow initial reponse 4. Chromosomal abnormalities |
|
Hodgkins Disease: Age Range
|
Ages 15-19 (And another ~ 50y)
|
|
Hodgkins Disease: Histo
|
Reed-Sternberg Cell: Large cell w/ multilobulated nuclei
*Four subtypes |
|
Hodgkins Disease: Possible etiology
|
EBV (But more associated with NHL)
Immunodeficiencies do predispose |
|
Hodgkins Disease: Presentation
|
*Depends on tumor location
1. Painless, firm, cervical or supraclavicular nodes (#1) 2. Anterior mediastinal mass 3. Night sweats, fever, weight loss, lethargy, anorexia, pruritus (ITCHING) |
|
Hodgkins Disease: Dx
|
BEST: Bx of affected node
|
|
Hodgkins Disease: Staging Tests
|
CXR (All patient to look for mets)
CBC ESR, ferritin, Copper CT Chest abdomen Bone Marrow if III/IV |
|
Hodgkins Disease: Staging
|
I: Single node/site
II: Two+ nodes but same side diaphragm III: Both side diaphragm IV: Diffuse |
|
Hodgkins Disease: Tx Determined by
|
1. Disease stage, patient age
2. Size of mass 3. Hilar nodes |
|
Hodgkins Disease: Tx modalities
|
Chemo
Radiation |
|
NHL: Origins
|
*Malignant proliferation of lymphocytes: T, B, or intermediate origin
|
|
NHL: Ages vs. Hodgkins
|
- Younger
|
|
NHL: Possible etiology
|
EBC - Major role in Burkitts
1. 95% EBV genome in equatorial africa 2. Also congenital or acquired immunodeficiency predispose |
|
NHL: Subtypes
|
1. Lymphoblastic -- Usually T
2. Small, noncleaved cell lymphoma -- B 3. Large Cell -- T, B, Intermediate |
|
NHL: Presentation
|
*Depends on Locations
1. Anterior Mediastinal mass = respiratory Sx 2. Abdominal pain, mass, possible constipation |
|
NHL: Dx
|
- Prompt b/c it's a very aggressive disease
1. Bx 2. Noninvasive: CT, CXR, Etc |
|
NHL: St. Jude Staging System
|
I. Localized
II. Regional w/o mediastinal III. Mediastinal/extensive IV. Disseminated |
|
NHL: Tx
|
1. Surgical excision of tumor if accessible
2. Chemo: To shrink 3. Radiation for some |
|
NHL: Cure Rate
|
90% at 5-y for I and II
|
|
Most common solid tumors in children
|
Brain tumors (combined) -- 2nd most common cancers overall
|
|
Brain Tumors: Mortality
|
45% (Also highest morbidity)
|
|
Brain Tumors: Age Range
|
Most < 7y
|
|
Brain Tumors: Sites
|
2/3 are infratentorial
|
|
Suspected Brain Tumors: Best initial Test
|
Head CT
|
|
Brain Tumors Location + Type: 0-1y
|
Supratentorial
*Choroid Plexus + Teratomas |
|
Brain Tumors Location + Type: 2-10y
|
Infratentorial
*Juvenile pilocytic astrocytoma *Medulloblastoma (often supratentorial) |
|
Brain Tumors Location + Type: > 10y
|
Supratentorial
*Diffuse astrocytoma |
|
Most common brain tumor histology overall:
|
Astrocytoma
|
|
Infratentorial Tumors: Most common and Outcomes
|
*Astrocytoma most common --> Juvenile pilocytic most common sub-type
*Low grade; rarely invasive |
|
Classic site of Astrocytoma:
|
Cerebellum
|
|
Astrocytoma: Tx
|
Surgery + Chemo/Rads
|
|
Astrocytoma: Survival
|
80-100% IF COMPLETE RESECTION
|
|
Infratentorial Malignant Varieties:
|
Malignant Astrocytoma (diffuse or fibrillary)
a. Anaplastic b. Glioblastoma multiform --> Poor outcome |
|
Embryonal Brain tumors Include:
|
Medullloblastoma (90%)
|
|
Medulloblastoma: Ages
|
Most or males 5-7y
|
|
Medulloblastoma: Site
|
Midline cerebellar vermis (most)
|
|
Medulloblastoma: CT findings
|
Solid, homengenous mass in postieor fossa
|
|
Medulloblastoma: Obstructive Complications
|
*Blocks 4th ventricle --> hydrocephalus --> Vomiting/ICP
|
|
Medulloblastoma: Tx / Survival
|
Chemo-Rads
*60-70% survival |
|
Third Most frequent tumor site?
|
- Brainstem
|
|
Brainstem tumors: Presentation
|
- Motor weakness, CN deficits, cerebellar deficits (gait), signs of increased ICP
|
|
Brainstem tumors: Varieties and outcomes
|
- Low grade gliomas --> Surgery, OK outcome
- Diffuse intrinsic: Rads, palliative --> Very poor outcome |
|
Brainstem tumors: Survival if diffuse intrinsic
|
Mean 12 mo
|
|
Fourth most common Brain tumor: Name and % overall
|
Ependymal Tumors (Ependymoma most common) - 10 % overall
|
|
Ependymal Tumors: Site
|
*From ependymal lining of ventricular system
*70% in posterior fossa --> 10% spread |
|
Ependymal Tumors: CT findings
|
Well circumscribed, generally non-invasive
|
|
Ependymal Tumors: Tx
|
Surgery + Radiation (Chemo OK)
|
|
Supratentorial Tumors: Key one to know? % of all?
|
Craniopharyngioma --> 7-10% = most common supratentorial
|
|
Craniopharyngioma: Site
|
- Suprasellar region
|
|
Craniopharyngioma: Aggressiveness
|
Minimal
|
|
Craniopharyngioma: Imaging Findings
|
Calcification seen on X-Ray
|
|
Craniopharyngioma: When to Think of?
|
- Mass effect findings or --> Decreased growth and child endocrine deficits
|
|
Craniopharyngioma: Morbidity
|
Panhypopituitarism, growth failure, visual loss
|
|
Craniopharyngioma: W/u and Tx
|
- Endocrine studies
- Surgery and Rads --> NO CHEMO *Hormone replacement after removal |
|
Eye Tumors: Most common
|
Optic Nerve Gliomas:
*Most frequent tumor of the optic nerve |
|
Optic Nerve Gliomas: Histology
|
Juvenile pilocytic astrocytoma
|
|
Optic Nerve Gliomas: Course
|
Benign, slowly progressive
|
|
Optic Nerve Gliomas: Sx
|
Unilateral vision loss + Proptosis + Eye deviation
*Optic atrophy *Nystagmus *Strabismus |
|
Optic Nerve Gliomas: Genetic Risk?
|
- Neurofibromatosis
|
|
Optic Nerve Gliomas: Tx
|
*Observation initially
Chiasm: Radiation/Chemo Surgery --> When confined or unsightly proptosis w/ visual loss or w/ visual deficits |